14.97
1.56%
0.23
アフターアワーズ:
14.70
-0.27
-1.80%
前日終値:
$14.74
開ける:
$14.62
24時間の取引高:
27,142
Relative Volume:
0.55
時価総額:
$1.40B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+11.14%
6か月 パフォーマンス:
-1.12%
1年 パフォーマンス:
+0.00%
Gyre Therapeutics Inc Stock (GYRE) Company Profile
名前
Gyre Therapeutics Inc
セクター
電話
(619) 949-3681
住所
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-04-29 | 再開されました | Stephens | Overweight |
2021-02-10 | 開始されました | Piper Sandler | Overweight |
2020-05-21 | 開始されました | Raymond James | Outperform |
2019-01-04 | 開始されました | Oppenheimer | Outperform |
2018-02-12 | 繰り返されました | B. Riley FBR, Inc. | Buy |
2018-02-09 | 繰り返されました | Chardan Capital Markets | Buy |
2017-12-08 | 開始されました | B. Riley FBR, Inc. | Buy |
2017-06-12 | 開始されました | Chardan Capital Markets | Buy |
2017-06-06 | 開始されました | Ladenburg Thalmann | Buy |
2016-06-30 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Gyre Therapeutics Inc (GYRE) 最新ニュース
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat
AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpStill a Buy? - MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World
Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World
Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat
Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat
Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat
Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat
Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat
GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace
Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan
Gyre Therapeutics (NASDAQ:GYRE) versus Insmed (NASDAQ:INSM) Critical Comparison - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 18.9% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 8.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 4.9% - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 67.9% in July - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.3% - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.3% - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - Defense World
Supply@ME Capital (LON:SYME) Stock Price Up 16.7% - Defense World
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Update - Defense World
Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE) - Defense World
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Up 15.1% in June - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 5.5% - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.3% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Up 3.7% - Defense World
Gyre Therapeutics faces Nasdaq delisting over audit rule - Investing.com India
Gyre Therapeutics faces Nasdaq delisting over audit rule By Investing.com - Investing.com
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle - TipRanks
Gyre Therapeutics Inc (GYRE) 財務データ
Gyre Therapeutics Inc (GYRE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Gyre Therapeutics Inc (GYRE) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
USMAN NASSIM | Director |
Jun 28 '24 |
Sale |
12.00 |
3,452 |
41,438 |
1,636 |
USMAN NASSIM | Director |
May 01 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
May 01 '24 |
Sale |
14.13 |
20,000 |
282,577 |
1,636 |
USMAN NASSIM | Director |
Apr 01 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
Apr 01 '24 |
Sale |
16.15 |
20,000 |
323,000 |
1,636 |
USMAN NASSIM | Director |
Mar 15 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
Mar 15 '24 |
Sale |
17.26 |
20,000 |
345,200 |
1,636 |
大文字化:
|
ボリューム (24 時間):